ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO169

Contribution of Endogenous Oxalate Synthesis to Urinary Oxalate Excretion

Session Information

Category: Bone and Mineral Metabolism

  • 402 Bone and Mineral Metabolism: Clinical


  • Fargue, Sonia, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
  • Knight, John, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States

Urinary oxalate excretion is a known risk factor for calcium oxalate kidney stones and dietary oxalate absorption can contribute to 50% of urinary oxalate. In the absence of adequate dietary control, the rate of endogenous synthesis of oxalate is unknown. Using isotope tracer methodology, we determined the turnover rate of oxalate in healthy volunteers and compared it with urinary excretions on a controlled diet.


A primed, continuous infusion of 13C2-oxalate was administered for 5 hrs in the fasted state to 16 healthy adults (7M/9F) between 24 and 56 years of age and BMI 23-44 kg/m2 after 2 days of equilibration on a low oxalate, normal calcium fixed diet. Blood and urine were collected for analysis of oxalate by Ion Chromatography coupled with Mass Spectrometry and the rate of oxalate turnover rate calculated using urine 13C2-oxalate mole percent enrichments at steady-state. Two 24-hr urines and 5 hourly urines in the fasted state were collected after dietary equilibration. Body composition was assessed by impedance.


Mean 24-hr urinary oxalate excretion on the fixed diet was 20 ± 4 mg oxalate/day (range 12-28 mg/day), or 13 ± 3 mg oxalate/g creatinine. Projected 24-hr urinary oxalate was 17 ± 4 mg/day using fasted hourly collections. Isotopic equilibration was achieved within 3 hrs for most subjects. Mean urine enrichment with 13C2-oxalate at steady-state was 19 ± 5%. Mean plasma enrichment at steady-state was 19 ± 1% in a subset of subjects analyzed. Average recovery rate of 13C2-oxalate infused was 100 ± 10%. Oxalate turnover rate was 107 ± 26 nmol/hr/kg and endogenous oxalate synthesis 17 ± 4 mg/day (range 11-24 mg/day, 19 ± 4 and 16 ± 4 mg/day for males and females, respectively). There was a positive correlation between lean body mass and oxalate endogenous synthesis.


The range of oxalate synthesis rates spanned a two-fold interval even under fasting conditions and the use of fixed diet. The main factor associated with oxalate synthesis was lean body mass. There was good agreement with 24-hr and fasting hourly urinary oxalate excretions under these conditions. Future studies in oxalate kidney stone formers will address whether endogenous synthesis of oxalate is increased in this population and what factors underlie oxalate turnover.


  • NIDDK Support